Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
May 14, 2026 | #ASCO26 #medscapeoncology, MedEd
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
Three Symposia at the Hilton Chicago
- The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps — Saturday, May 30, 6:15–7:45 PM CT, International Ballroom South. Supported by Bayer.
- Redefining the Patient Journey: The Promise and Practice in NTRK Fusion-Positive Cancers — Sunday, May 31, 6:30–8:00 PM CT, International Ballroom South. Supported by Bayer.
- A Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma — Sunday, May 31, 6:30–7:30 PM CT, International Ballroom North. Supported by Sanofi, in partnership with the International Myeloma Foundation.
Online Poster
Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD
ASCO Fellows, Year Three
For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program.
“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education.
Medscape AI on the Booth
Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.
An Indispensable Resource for Oncologists
Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.
Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Power of AI in Medical Education
Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education…
Connect to the conversation around mental health: A spotlight on physician burnout
For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians — burnout. Every year, Medscape surveys thousands of…
MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation
WHAT’S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the…
It’s a Medscape wrap for EHA2022
EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters…
Part 4 of 4, of the Medscape video interview series
Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients…
Part 3 of the Medscape video series #EHA
Ahead of Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr. Naval Daver on the most important abstracts to look out for in Myeloid and…
Part 2 of the Medscape video interview series
Ahead of Europe’s largest haematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer interviews Dr. John Gribben on the most important abstracts to look out for in CLL and the…
A Medscape Oncology exclusive preview
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in…
Part 1 of the Medscape video interview series
Ahead of Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr Loretta Nastoupil on the most important abstracts to look out for at EHA in lymphoma…
Medscape: Connect to the conversation
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in…